Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Aug:152:103639.
doi: 10.1016/j.jri.2022.103639. Epub 2022 May 10.

Comment to "Pregnancy and COVID-19, focus on vaccine and pharmacological treatment"

Michael Ceulemans  1 , Laure Sillis  2 , Veerle Foulon  2 , Alice Panchaud  3 , Ursula Winterfeld  4 , Léo Pomar  5 , Brian Cleary  6 , Fergal O'Shaughnessy  6 , Anneke Passier  7 , Jonathan Luke Richardson  8 , Hedvig Nordeng  9
Affiliations
Comment

Comment to "Pregnancy and COVID-19, focus on vaccine and pharmacological treatment"

Michael Ceulemans et al. J Reprod Immunol. 2022 Aug.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Antonucci R., Zaffanello M., Puxeddu E., Porcella A., Cuzzolin L., Pilloni M.D., Fanos V. Use of non-steroidal anti-inflammatory drugs in pregnancy: impact on the fetus and newborn. Curr. Drug Metab. 2012;13(4):474–490. doi: 10.2174/138920012800166607. - DOI - PubMed
    1. Ceulemans M., Foulon V., Panchaud A., Winterfeld U., Pomar L., Lambelet V., Cleary B., O’Shaughnessy F., Passier A., Richardson J.L., Nordeng H. Self-Reported Medication Use among Pregnant and Breastfeeding Women during the COVID-19 Pandemic: A Cross-Sectional Study in Five European Countries. Int J. Environ. Res Public Health. 2022;19(3):1389. doi: 10.3390/ijerph19031389. - DOI - PMC - PubMed
    1. Food Drug Administration, 2020, FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later because they can result in low amniotic fluid. 〈https://www.fda.gov/drugs/drug-safety-and-availability/fda-recommends-av....
    1. Gerbier E., Favre G., Tauqeer F., Winterfeld U., Stojanov M., Oliver A., Passier A., Nordeng H., Pomar L., Baud D., Panchaud A., Meyer-Massetti C., Ceulemans M. Self-reported medication use among pregnant and postpartum women during the third wave of the COVID-19 pandemic: a European multinational cross-sectional study. Int J. Environ. Res Public Health. 2022;19(9) doi: 10.3390/ijerph19095335. - DOI - PMC - PubMed
    1. Vitiello A., Ferrara F., Zovi A., Trama U., Boccellino M. Pregnancy and COVID-19, focus on vaccine and pharmacological treatment. J. Reprod. Immunol. 2022 doi: 10.1016/j.jri.2022.103630. - DOI - PMC - PubMed